BiotechTube
Home/Pipeline/YZY-002

YZY-002

Hematological Malignancies

Phase 1Active

Key Facts

Indication
Hematological Malignancies
Phase
Phase 1
Status
Active
Company
YZY Biopharma

About YZY Biopharma

Clinical-stage biotech developing bispecific antibody therapeutics for oncology and immunology using proprietary T-cell engager technology.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Hematological Malignancies Drugs

DrugCompanyPhase
NST-201 (estimated)Novastage PharmaceuticalsPreclinical/IND-enabling
TYK-201TYK MedicinesPreclinical
TNB-655Tenacia BiotechnologyPreclinical
Undisclosed CAR-T ProgramOBiO TechnologyPhase 1/2
NP-G2-044Novita PharmaceuticalsPhase 2a
PS-102Perimeter Systems, Inc.Preclinical
JaxBio Hematology Cancer TestJaxBioPreclinical